Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$3.03 - $3.79 $168,749 - $211,076
55,693 New
55,693 $195,000
Q2 2022

Aug 15, 2022

SELL
$5.13 - $9.2 $118,918 - $213,265
-23,181 Reduced 29.39%
55,693 $314,000
Q1 2022

May 11, 2022

BUY
$8.64 - $11.71 $165,369 - $224,129
19,140 Added 32.04%
78,874 $681,000
Q4 2021

Feb 11, 2022

BUY
$10.95 - $16.07 $9,066 - $13,305
828 Added 1.41%
59,734 $665,000
Q3 2021

Nov 12, 2021

BUY
$12.95 - $18.24 $61,991 - $87,314
4,787 Added 8.85%
58,906 $763,000
Q2 2021

Aug 11, 2021

SELL
$15.83 - $17.84 $115,337 - $129,982
-7,286 Reduced 11.87%
54,119 $896,000
Q1 2021

May 13, 2021

BUY
$15.92 - $20.3 $20,584 - $26,247
1,293 Added 2.15%
61,405 $1.05 Million
Q4 2020

Feb 09, 2021

SELL
$15.65 - $19.92 $45,212 - $57,548
-2,889 Reduced 4.59%
60,112 $940,000
Q3 2020

Nov 12, 2020

SELL
$13.97 - $21.16 $6,440 - $9,754
-461 Reduced 0.73%
63,001 $1.2 Million
Q2 2020

Aug 12, 2020

BUY
$10.39 - $16.07 $160,847 - $248,779
15,481 Added 32.26%
63,462 $870,000
Q1 2020

May 06, 2020

SELL
$8.89 - $24.94 $158,473 - $444,580
-17,826 Reduced 27.09%
47,981 $509,000
Q4 2019

Feb 14, 2020

BUY
$8.33 - $19.95 $64,207 - $153,774
7,708 Added 13.27%
65,807 $1.23 Million
Q3 2019

Nov 07, 2019

BUY
$6.86 - $10.46 $34,046 - $51,912
4,963 Added 9.34%
58,099 $607,000
Q2 2019

Aug 12, 2019

BUY
$6.99 - $11.27 $254,540 - $410,397
36,415 Added 217.78%
53,136 $403,000
Q1 2019

May 14, 2019

SELL
$5.05 - $11.62 $2,560 - $5,891
-507 Reduced 2.94%
16,721 $184,000
Q3 2018

Nov 09, 2018

SELL
$2.31 - $4.69 $11 - $23
-5 Reduced 0.03%
17,228 $0
Q2 2018

Aug 06, 2018

SELL
$4.04 - $5.13 $178,822 - $227,069
-44,263 Reduced 71.98%
17,233 $77,000
Q1 2018

May 15, 2018

BUY
$3.92 - $5.35 $15,417 - $21,041
3,933 Added 6.83%
61,496 $329,000
Q4 2017

Feb 09, 2018

BUY
$3.9 - $4.66 $224,495 - $268,243
57,563
57,563 $227,000

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $203M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.